These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 3287160)
1. 5-ASA for ulcerative colitis. Meyers S; Janowitz HD N Engl J Med; 1988 Jun; 318(24):1620-1. PubMed ID: 3287160 [No Abstract] [Full Text] [Related]
2. Oral mesalamine for ulcerative colitis. Med Lett Drugs Ther; 1992 Aug; 34(877):80-1. PubMed ID: 1353858 [No Abstract] [Full Text] [Related]
3. Mesalamine for ulcerative colitis. Med Lett Drugs Ther; 1988 May; 30(766):53-4. PubMed ID: 3283508 [No Abstract] [Full Text] [Related]
4. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease. Segars LW; Gales BJ Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685 [TBL] [Abstract][Full Text] [Related]
5. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. Habal FM; Greenberg GR Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391 [TBL] [Abstract][Full Text] [Related]
7. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas. Barber GB; Lee DE; Antonioli DA; Peppercorn MA Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789 [TBL] [Abstract][Full Text] [Related]
8. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Andreoli A; Spinella S; Levenstein S; Prantera C Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759 [TBL] [Abstract][Full Text] [Related]
9. [5-Aminosalicylic acid--a new therapeutic possibility in chronic inflammatory bowel disease]. Hartmann F Leber Magen Darm; 1986 Jan; 16(1):20-7. PubMed ID: 3515082 [No Abstract] [Full Text] [Related]
10. Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease. Sonu I; Lin MV; Blonski W; Lichtenstein GR Gastroenterol Clin North Am; 2010 Sep; 39(3):559-99. PubMed ID: 20951918 [TBL] [Abstract][Full Text] [Related]
11. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission. Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895 [No Abstract] [Full Text] [Related]
12. Oral asacol in the treatment of mild to moderate ulcerative colitis: the Nashville experience. Pruitt RE; Gremillion DE; Herring RW; Bailey AH; Faust TW; Potter M; Long KM J Tenn Med Assoc; 1991 May; 84(5):237. PubMed ID: 2067380 [No Abstract] [Full Text] [Related]
13. Topical salicylate therapy (4-ASA and 5-ASA enemas). Ginsberg AL Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990 [TBL] [Abstract][Full Text] [Related]
14. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Marshall JK; Irvine EJ Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961 [TBL] [Abstract][Full Text] [Related]
15. Choosing an oral 5-aminosalicylic acid preparation for ulcerative colitis. Drug Ther Bull; 1992 Jun; 30(13):50-2. PubMed ID: 1628539 [No Abstract] [Full Text] [Related]
16. Sulfasalazine and new analogues. Friedman G Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653 [No Abstract] [Full Text] [Related]
17. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention. Sandborn WJ Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478 [TBL] [Abstract][Full Text] [Related]
18. Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update. Martin F Dig Dis Sci; 1987 Dec; 32(12 Suppl):57S-63S. PubMed ID: 2891469 [TBL] [Abstract][Full Text] [Related]
19. [5-aminosalicylic acid in the long-term treatment of ulcerative colitis]. Breuer N Z Gastroenterol; 1989 Apr; 27(4):234-5. PubMed ID: 2499133 [No Abstract] [Full Text] [Related]